Skip to main content

biote Corp

For the period ended Dec 31, 2023. Filed Mar 15, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 15, 2024

BTMD$1.08-2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Income (Loss) And Comprehensive Income (Loss)

(in thousands, except share and per share amounts)

Year Ended December 31,
20232022
Revenue:
Product revenue$182,573$163,133
Service revenue2,7871,824
Total revenue185,360164,957
Cost of revenue
Cost of products54,24651,990
Cost of services3,6312,585
Cost of revenue57,87754,575
Selling, general and administrative98,826171,104
Income (loss) from operations28,657(60,722)
Other income (expense), net:
Interest expense, net(6,363)(4,047)
Gain (loss) from change in fair value of warrant liability(13,411)5,127
Gain (loss) from change in fair value of earnout liability(8,990)61,770
Loss from extinguishment of debt—(445)
Other income (expense)(16)29
Total other income (expense), net(28,780)62,434
Income (loss) before provision for income taxes(123)1,712
Income tax expense2,682388
Net income (loss)(2,805)1,324
Less: Net income (loss) attributable to noncontrolling interest(6,121)2,293
Net income (loss) attributable to biote Corp. stockholders$3,316$(969)
Other comprehensive income (loss):
Foreign currency translation adjustments8(1)
Other comprehensive income (loss)8(1)
Comprehensive income (loss)$(2,797)$1,323
Net income (loss) per common share
Basic$0.13$(0.12)
Diluted$0.13$(0.12)
Weighted average common shares outstanding
Basic25,709,3438,059,371
Diluted25,709,3438,059,371
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.